In Silico–Based Structural Analysis of Arylthiophene Derivatives for FTase Inhibitory Activity, hERG, and Other Toxic Effects

In the present investigation, the authors have performed an in silico–based analysis on a series of arylthiophene derivatives for the determination of their structural features responsible for farnesyltransferase (FTase) inhibitory activity, hERG blocking activity, and toxicity by quantitative structure–activity relationship and pharmacophore analysis techniques. The statistically significant models derived through multiple linear regression analysis were validated by different validation methods. The applicability of the descriptors contributed in the selected models show that the polar and polarizable properties on the van der Waals (vdW) surface area of the molecules are important for the FTase inhibitory and hERG blocking activities, while being detrimental for the toxicity of the molecules. It is interesting to note that the topological properties, molecular flexibility, and connectivity of the molecules are positively correlated to all the activities (FTase inhibition, hERG blocking, and toxicity). This implies that the flexibility of the molecules is the common feature for interaction in all targets, whereas the presence of polar groups on the molecular surface (vdW) is a determinant for the favorable (FTase inhibition) or unwanted effect (hERG blocking and toxicity) of the molecules. The pharmacophore analysis of the molecules demonstrated that the aromatic/hydrophobicity and polarizability features are important pharmacophore contours favorable for these activities.

[1]  J. Durbin,et al.  Testing for serial correlation in least squares regression. I. , 1950, Biometrika.

[2]  J. Gasteiger,et al.  ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .

[3]  N. S. Hari Narayana Moorthy,et al.  Synthesis, cytotoxic evaluation and in silico pharmacokinetic prediction of some benzo[a]phenazine-5-sulfonic acid derivatives. , 2009, Medicinal chemistry (Shariqah (United Arab Emirates)).

[4]  Pedro Alexandrino Fernandes,et al.  Theoretical studies on farnesyltransferase: The distances paradox explained , 2006, Proteins.

[5]  Sérgio F. Sousa,et al.  Molecular dynamics analysis of farnesyltransferase: A closer look into the amino acid behavior , 2008 .

[6]  QSAR analysis of 2-benzoxazolyl hydrazone derivatives for anticancer activity and its possible target prediction , 2012, Medicinal Chemistry Research.

[7]  N. S. Hari Narayana Moorthy,et al.  Design, synthesis, cytotoxic evaluation, and QSAR study of some 6H-indolo[2,3-b]quinoxaline derivatives , 2010, Journal of enzyme inhibition and medicinal chemistry.

[8]  P. Fernandes,et al.  Structural feature study of benzofuran derivatives as farnesyltransferase inhibitors , 2011, Journal of enzyme inhibition and medicinal chemistry.

[9]  P. Angibaud,et al.  Farnesyl protein transferase inhibitor ZARNESTRA R115777 - history of a discovery. , 2003, Current topics in medicinal chemistry.

[10]  QSAR and pharmacophore analysis of thiosemicarbazone derivatives as ribonucleotide reductase inhibitors , 2012, Medicinal Chemistry Research.

[11]  D. Heimbrook,et al.  Potent N-(1,3-thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channel. , 2004, Journal of medicinal chemistry.

[12]  Inhibitors of farnesyltransferase: a rational approach to cancer chemotherapy? , 2004, Journal of medicinal chemistry.

[13]  A. Tropsha,et al.  Beware of q2! , 2002, Journal of molecular graphics & modelling.

[14]  P. Casey,et al.  Cocrystal structure of protein farnesyltransferase complexed with a farnesyl diphosphate substrate. , 1998, Biochemistry.

[15]  N. S. Hari Narayana Moorthy,et al.  Quantitative structure-activity relationships of selective antagonists of glucagon receptor using QuaSAR descriptors. , 2006, Chemical & pharmaceutical bulletin.

[16]  R. Doll,et al.  Farnesyl protein transferase inhibition: a novel approach to anti-tumor therapy. the discovery and development of SCH 66336. , 2001, Current medicinal chemistry.

[17]  P. Roy,et al.  On Some Aspects of Variable Selection for Partial Least Squares Regression Models , 2008 .

[18]  Pedro Alexandrino Fernandes,et al.  Theoretical studies on farnesyl transferase: Evidence for thioether product coordination to the active‐site zinc sphere , 2007, J. Comput. Chem..

[19]  Márcia M. C. Ferreira,et al.  Basic validation procedures for regression models in QSAR and QSPR studies: theory and application , 2009 .

[20]  A. Tropsha,et al.  Beware of q 2 , 2002 .

[21]  P. K. Basniwal,et al.  2-(4-aminophenyl) benzothiazole: a potent and selective pharmacophore with novel mechanistic action towards various tumour cell lines. , 2006, Mini reviews in medicinal chemistry.

[22]  V. D. da Silva,et al.  Computer-aided drug design and ADMET predictions for identification and evaluation of novel potential farnesyltransferase inhibitors in cancer therapy. , 2010, Journal of molecular graphics & modelling.

[23]  J. Durbin,et al.  Testing for serial correlation in least squares regression. II. , 1950, Biometrika.

[24]  C. Leem,et al.  A novel hypothesis for the binding mode of HERG channel blockers. , 2006, Biochemical and biophysical research communications.

[25]  Pedro Alexandrino Fernandes,et al.  Molecular dynamics simulations on the critical states of the farnesyltransferase enzyme. , 2009, Bioorganic & medicinal chemistry.

[26]  M. Sakaitani,et al.  Synthesis and structure-activity relationships of novel benzofuran farnesyltransferase inhibitors. , 2009, Bioorganic & medicinal chemistry letters.

[27]  C. Karthikeyan,et al.  QSAR study of substituted 2-pyridinyl guanidines as selective urokinase-type plasminogen activator (uPA) inhibitors , 2009 .

[28]  P. Fernandes,et al.  QSAR Analysis of Isosteviol Derivatives as α-Glucosidase Inhibitors with Element Count and Other Descriptors , 2011 .

[29]  J. Dubois,et al.  Discovery of a new class of protein farnesyltransferase inhibitors in the arylthiophene series. , 2009, Journal of medicinal chemistry.

[30]  P. Fernandes,et al.  Prediction of the relationship between the structural features of andrographolide derivatives and α-glucosidase inhibitory activity: A quantitative structure-activity relationship (QSAR) Study , 2011, Journal of enzyme inhibition and medicinal chemistry.